Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
1.320
+0.020 (1.54%)
At close: Apr 7, 2026, 4:00 PM EDT
1.300
-0.020 (-1.52%)
After-hours: Apr 7, 2026, 7:48 PM EDT
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $45.38 million as of April 7, 2026. Its market cap has decreased by -62.63% in one year.
Market Cap
45.38M
Enterprise Value
37.88M
1-Year Change
-62.63%
Ranking
Category
Stock Price
$1.32
Market Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $45.38M, a decrease of -78.10%. That is a compound annual growth rate of -50.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 44.70M | -2.26% |
| Dec 31, 2025 | 45.73M | -62.70% |
| Dec 31, 2024 | 122.58M | -40.86% |
| Feb 9, 2024 | 207.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aligos Therapeutics | 48.88M |
| Nutriband | 46.33M |
| Rein Therapeutics | 45.70M |
| Lisata Therapeutics | 45.16M |
| Immutep | 44.84M |
| Rallybio | 43.48M |
| Sensei Biotherapeutics | 43.06M |
| Atossa Therapeutics | 41.55M |